At a glance
ClinicalIndex Comparison RecordN/ACompleted· 24 enrolled
Drug / intervention
ARGOS-IO systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Open-label, Multicenter Clinical Investigation to Assess the Safety and Performance of the ARGOS-IO System in Patients With Primary Open Angle Glaucoma (POAG)
In Brief
A clinical study evaluating ARGOS-IO system for Primary Open Angle Glaucoma (POAG). Completed, enrolled 24 participants across 11 sites.
Detailed Summary
The purpose of this study is to evaluate the safety and performance of the ARGOS-IO system in patients with POAG and indicated cataract surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPrimary Open Angle Glaucoma (POAG)
CountriesGermany
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartJul 2014
First PostedMay 2015
Primary CompletionApr 2017
TodayJul 2026
First PostedMay 5, 2015
Enrollment StartJul 9, 2014
Primary CompletionApr 11, 2017
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 11.2 years ago
Interventions
ARGOS-IO systemdevice
Implantation of ARGOS-IO pressure sensor after IOL placement within the cataract surgical procedure on day 0 (V01)